Patheon launches IPO
Patheon NV has launched its IPO a year after announcing its intention to go public.
Patheon NV has launched its IPO a year after announcing its intention to go public.
AMRI has completed the acquisition of Italian API firm Euticals for €315m ($350m).
The Precision Medicine Initiative (PMI) Cohort Program is expected to launch later this year with the goal of enrolling more than one million US participants by 2020.
The FDA has placed on clinical hold on Juno’s Ph II clinical trial of JCAR015 following the death of two patients last week and will “continue to work” to ensure patient safety, says representative.
Pluristem has said it will begin a US trial of a cell therapy for people lacking bone marrow this year after hiring a CRO.